{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:09:26Z","timestamp":1778843366012,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004008","name":"Istituto Superiore di Sanit\u00e0","doi-asserted-by":"publisher","award":["BFC2"],"award-info":[{"award-number":["BFC2"]}],"id":[{"id":"10.13039\/501100004008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.msard.2022.104069","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T12:42:43Z","timestamp":1658493763000},"page":"104069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["EBV as the \u2018gluten of MS\u2019 hypothesis: Bypassing autoimmunity"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9193-0075","authenticated-orcid":false,"given":"Francesca","family":"Aloisi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Veroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7796","key":"10.1016\/j.msard.2022.104069_bib0001","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-020-2003-8","article-title":"IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease","volume":"578","author":"Abadie","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.msard.2022.104069_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003220","article-title":"Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis","volume":"9","author":"Angelini","year":"2013","journal-title":"PLoS Pathog."},{"issue":"6578","key":"10.1016\/j.msard.2022.104069_bib0003","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.msard.2022.104069_bib0004","doi-asserted-by":"crossref","first-page":"eabn1823","DOI":"10.1126\/sciadv.abn1823","article-title":"Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis","volume":"8","author":"Bronge","year":"2022","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.msard.2022.104069_bib0005","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1371\/journal.pone.0000664","article-title":"HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis","volume":"2","author":"Brynedal","year":"2007","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.msard.2022.104069_bib0006","doi-asserted-by":"crossref","first-page":"e1119","DOI":"10.1212\/NXI.0000000000001119","article-title":"Stress signal ULBP4, an NKG2D ligand, is upregulated in multiple sclerosis and shapes CD8+ T-cell behaviors","volume":"9","author":"Carmena Moratalla","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"64","key":"10.1016\/j.msard.2022.104069_bib0007","article-title":"EBV as the \"gluten of MS\" hypothesis provides a rationale for trialing antiviral therapies","volume":"1","author":"Drosu","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.104069_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103087","article-title":"Probing the association between multiple sclerosis and Epstein Barr virus from a therapeutic perspective","volume":"52","author":"Drosu","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.104069_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192109","article-title":"Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells","volume":"13","author":"Hassani","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2022.104069_bib0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2022.104069_bib0011","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3389\/fneur.2019.01368","article-title":"High levels of Epstein-Barr virus nuclear antigen-1-specific antibodies and infectious mononucleosis act both independently and synergistically to increase multiple sclerosis risk","volume":"10","author":"Hedstr\u00f6m","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2022.104069_bib0012","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1474-4422(15)00313-0","article-title":"The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research","volume":"15","author":"Hohlfeld","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2022.104069_bib0013","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/13550280490261671","article-title":"Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells","volume":"10","author":"Holm\u00f8y","year":"2004","journal-title":"J. Neurovirol."},{"issue":"6487","key":"10.1016\/j.msard.2022.104069_bib0014","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1126\/science.aay3037","article-title":"Autoimmunity provoked by foreign antigens","volume":"368","author":"Iversen","year":"2020","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.msard.2022.104069_bib0015","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.4049\/jimmunol.1601693","article-title":"T cells in celiac disease","volume":"198","author":"Jabri","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2022.104069_bib0016","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/eji.200939761","article-title":"Intrathecal immune responses to EBV in early MS","volume":"40","author":"Jaqui\u00e9ry","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.msard.2022.104069_bib0017","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41591-019-0523-2","article-title":"A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis","volume":"25","author":"Johnson","year":"2019","journal-title":"Nat. Med."},{"issue":"7900","key":"10.1016\/j.msard.2022.104069_bib0018","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.msard.2022.104069_bib0019","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/biomedicines10030609","article-title":"Checkpoint inhibitors and induction of celiac disease-like condition","volume":"10","author":"Lerner","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.msard.2022.104069_bib0020","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3389\/fimmu.2019.02193","article-title":"The T-cell response to Epstein-Barr virus - new tricks from an old dog","volume":"10","author":"Long","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2022.104069_bib0021","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2011.09.011","article-title":"Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis","volume":"240-241","author":"Lossius","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2022.104069_bib0022","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1084\/jem.20072397","article-title":"EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2","volume":"205","author":"L\u00fcnemann","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.msard.2022.104069_bib0023","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.msard.2022.104069_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.877936","article-title":"PD-1\/PD-L axis in neuroinflammation: new insights","volume":"13","author":"Manenti","year":"2022","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2022.104069_bib0025","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.tig.2021.04.012","article-title":"Multiple sclerosis: doubling down on MHC","volume":"37","author":"Martin","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.msard.2022.104069_bib0026","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.1212\/NXI.0000000000000466","article-title":"Molecular signature of Epstein-Barr virus infection in MS brain lesions","volume":"5","author":"Moreno","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"22","key":"10.1016\/j.msard.2022.104069_bib0027","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124714","article-title":"Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis","volume":"3","author":"Pender","year":"2018","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.msard.2022.104069_bib0028","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40263-020-00704-w","article-title":"Anti-CD20 monoclonal antibodies for relapsing and progressive multiple sclerosis","volume":"34","author":"Sellebjerg","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.msard.2022.104069_bib0029","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/NEN.0000000000000082","article-title":"Epstein-Barr virus in the central nervous system and cervical lymph node of a patient with primary progressive multiple sclerosis","volume":"73","author":"Serafini","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.msard.2022.104069_bib0030","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J. Exp Med."},{"issue":"24","key":"10.1016\/j.msard.2022.104069_bib0031","doi-asserted-by":"crossref","first-page":"e00980","DOI":"10.1128\/JVI.00980-19","article-title":"Epstein-Barr virus-specific CD8 T cells selectively infiltrate the brain in multiple sclerosis and interact locally with virus-infected cells: clue for a virus-driven immunopathological mechanism","volume":"93","author":"Serafini","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.msard.2022.104069_bib0032","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jneuroim.2017.03.013","article-title":"Massive intracerebral Epstein-Barr virus reactivation in lethal multiple sclerosis relapse after natalizumab withdrawal","volume":"307","author":"Serafini","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2022.104069_bib0033","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/NEN.0b013e3181e332ec","article-title":"Epstein-barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation","volume":"69","author":"Serafini","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.msard.2022.104069_bib0034","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneuroim.2018.03.011","article-title":"Epstein-Barr virus-associated immune reconstitution inflammatory syndrome as possible cause of fulminant multiple sclerosis relapse after natalizumab interruption","volume":"319","author":"Serafini","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"70","key":"10.1016\/j.msard.2022.104069_bib0035","doi-asserted-by":"crossref","first-page":"eabo7799","DOI":"10.1126\/sciimmunol.abo7799","article-title":"Epstein-Barr virus as a driver of multiple sclerosis","volume":"7","author":"Sollid","year":"2022","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2022.104069_bib0036","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/gene.2011.42","article-title":"Epstein-Barr virus and multiple sclerosis: interaction with HLA","volume":"13","author":"Sundqvist","year":"2012","journal-title":"Genes Immun."},{"issue":"34","key":"10.1016\/j.msard.2022.104069_bib0037","doi-asserted-by":"crossref","first-page":"16955","DOI":"10.1073\/pnas.1902623116","article-title":"Molecular mimicry between anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk","volume":"116","author":"Tengvall","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.msard.2022.104069_bib0038","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1352458515588581","article-title":"Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins","volume":"22","author":"van Nierop","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.104069_bib0039","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00401-017-1744-4","article-title":"Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients","volume":"134","author":"van Nierop","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.msard.2022.104069_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12974-017-1049-5","article-title":"Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis","volume":"15","author":"Veroni","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2022.104069_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.665718","article-title":"The CD8 T cell-Epstein-Barr virus-B cell trialogue: a central issue in multiple sclerosis pathogenesis","volume":"12","author":"Veroni","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2022.104069_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105434","article-title":"A complex role of herpes viruses in the disease process of multiple sclerosis","volume":"9","author":"Wuest","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.msard.2022.104069_bib0043","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/eji.202048655","article-title":"Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15","volume":"51","author":"Zdimerova","year":"2020","journal-title":"Eur. J. Immunol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822005776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822005776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:28:41Z","timestamp":1778840921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822005776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":43,"alternative-id":["S2211034822005776"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.104069","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EBV as the \u2018gluten of MS\u2019 hypothesis: Bypassing autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.104069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104069"}}